Ahmed Bennis/X
Nov 17, 2026, 23:34
Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X about a recent article by John W. Eikelboom, published in NEJM, adding:
“Aspirin Therapy — Enough after Arthroplasty?
Results from the EPCAT III and PEPPER trials suggest that aspirin therapy from the outset after surgery is a reasonable option for many patients at standard risk for thrombosis, but the results do not establish that aspirin and anticoagulants provide equivalent protection against VTE.”
Title: Aspirin Therapy — Enough after Arthroplasty?
Authors: John W. Eikelboom

Other posts featuring Ahmed Bennis on Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding